Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
filingDate |
2001-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc2c8ce468d98a17624492451f84fcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c3fba549b2e5a3b0b4c47aab78fde2 |
publicationDate |
2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002161044-A1 |
titleOfInvention |
Method for enhanced delivery of oxybutynin and compositions thereof |
abstract |
This invention provides to a method for enhancement of systemic delivery of oxybutynin by administration via the nasal route, and methods of treatment comprising intranasal administration of oxybutynin. The present invention further provides pharmaceutical compositions comprising oxybutynin and/or pharmaceutically acceptable salts thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7029694-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005226898-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7081249-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7081251-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003124177-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005048106-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7081250-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7081252-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8241662-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6743441-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7179483-B2 |
priorityDate |
2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |